ClinicalTrials.Veeva

Menu

Comparative of Effects of Sublingual Misoprostol and Infusion Oxytocin in Reduction of Bleeding at Cesarean

S

Soudabeh Eshghi ali

Status and phase

Unknown
Phase 3
Phase 2

Conditions

Bleeding Intraoperative

Treatments

Drug: Misoprostol

Study type

Interventional

Funder types

Other

Identifiers

NCT01477840
Kermanshah University

Details and patient eligibility

About

The purpose of this study is to determine whether the effect of sublingual misoprostol is better than infusion oxytocin in reduction of blood loss at cesarean deliveries.

Full description

A total of 180 pregnant women with gestational age 37 weeks and over who underwent cesarean operation in Imam Reza hospital had elective or emergency procedure with incision in lower segment during one year recruitment. The patients were randomly assigned to undergo 200 micrograms misoprostol sublingual or 400 micrograms and infusion 20 unit oxytocin after spinal anesthesia. Main outcome measures: The length of surgery, bleeding volume, the need for transfusion, fever, tachycardia, and hypotension.

Enrollment

180 estimated patients

Sex

Female

Ages

15 to 44 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Indication of Cesarean Deliveries
  • Elective or Emergency with Incision in Lower Segment in Women with
  • Gestational Age more than 37 Weeks.

Exclusion criteria

  • Anemia
  • Multiple Pregnancy
  • Polyhydraminus
  • Prolonged Labor
  • Premature Rupture of Membrane and Patients had Previous History of Diabetes Mellitus
  • Hypertension
  • Cardiovascular Disease
  • Coagulopathy Disease

Trial design

180 participants in 1 patient group

Misoprostol
Experimental group
Treatment:
Drug: Misoprostol

Trial contacts and locations

1

Loading...

Central trial contact

Anisodowleh Nankali, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems